155 related articles for article (PubMed ID: 31289540)
61. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W
Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324
[TBL] [Abstract][Full Text] [Related]
62. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
Du Y; Shuai Y; Wang H; Li H; Li Y
Turk J Med Sci; 2023 Jun; 53(3):630-639. PubMed ID: 37476905
[TBL] [Abstract][Full Text] [Related]
63. Mir-5100 Mediates Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells Via Targeting SCAI.
Wei Z; Lyu B; Hou D; Liu X
J Invest Surg; 2021 Aug; 34(8):834-841. PubMed ID: 31851859
[TBL] [Abstract][Full Text] [Related]
64. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
Zheng H; Wang JJ; Yang XR; Yu YL
World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
[TBL] [Abstract][Full Text] [Related]
65. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
66. Serum Exosomes-Based Biomarker circ_0008928 Regulates Cisplatin Sensitivity, Tumor Progression, and Glycolysis Metabolism by miR-488/
Shi Q; Ji T; Ma Z; Tan Q; Liang J
Cancer Biother Radiopharm; 2023 Oct; 38(8):558-571. PubMed ID: 33661058
[No Abstract] [Full Text] [Related]
67. Quercetin suppresses the tumorigenesis of oral squamous cell carcinoma by regulating microRNA-22/WNT1/β-catenin axis.
Zhang C; Hao Y; Sun Y; Liu P
J Pharmacol Sci; 2019 Jun; 140(2):128-136. PubMed ID: 31257059
[TBL] [Abstract][Full Text] [Related]
68. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
Mao Y; Zhang W; Zhang R; Zuo J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
[TBL] [Abstract][Full Text] [Related]
69. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
[TBL] [Abstract][Full Text] [Related]
70. LncRNA GACAT1 targeting miRNA-149 regulates the molecular mechanism of proliferation, apoptosis and autophagy of oral squamous cell carcinoma cells.
Chen J; Chen X; Fu L; Chen J; Chen Y; Liu F
Aging (Albany NY); 2021 Aug; 13(16):20359-20371. PubMed ID: 34460438
[TBL] [Abstract][Full Text] [Related]
71. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
72. circ_0004872 inhibits proliferation, invasion, and glycolysis of oral squamous cell carcinoma by sponged miR-424-5p.
Dai Y; Zhu Y; Xu H
J Clin Lab Anal; 2022 Jul; 36(7):e24486. PubMed ID: 35576499
[TBL] [Abstract][Full Text] [Related]
73. miR-21 inhibitor sensitizes human OSCC cells to cisplatin.
Wang W; Songlin P; Sun Y; Zhang B; Jinhui W
Mol Biol Rep; 2012 May; 39(5):5481-5. PubMed ID: 22249446
[TBL] [Abstract][Full Text] [Related]
74. Overexpression of MicroRNA-27b Inhibits Proliferation, Migration, and Invasion via Suppression of MET Expression.
Zhou H; Liu Y; Xiao L; Hu Z; Xia K
Oncol Res; 2017 Jan; 25(1):147-154. PubMed ID: 28081743
[TBL] [Abstract][Full Text] [Related]
75. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
[TBL] [Abstract][Full Text] [Related]
76. circBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression.
Qiu L; Zheng L; Gan C; Deng W; Sun Y; Wang T
J Oral Pathol Med; 2021 Aug; 50(7):668-680. PubMed ID: 33382158
[TBL] [Abstract][Full Text] [Related]
77. Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction.
Wu HT; Chen WT; Li GW; Shen JX; Ye QQ; Zhang ML; Chen WJ; Liu J
Front Genet; 2019; 10():1328. PubMed ID: 32038705
[TBL] [Abstract][Full Text] [Related]
78. [Mechanism of long-chain noncoding RNA PCGEM1 in the regulation of the invasion and metastasis of oral squamous carcinoma cells via transforming growth factor β2/Smad2 signaling pathway].
Weng X; Li JS; Fan S
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Oct; 38(5):550-557. PubMed ID: 33085241
[TBL] [Abstract][Full Text] [Related]
79. circAP1M2 activates ATG9A-associated autophagy by inhibiting miR-1249-3p to promote cisplatin resistance in oral squamous cell carcinoma.
Wenhao R; Yali C; Shaoming L; Jingjing Z; Ling G; Keqian Z
J Cell Physiol; 2023 Nov; 238(11):2612-2624. PubMed ID: 37661341
[TBL] [Abstract][Full Text] [Related]
80. MicroRNA-222-3p participates in the development of oral squamous cell carcinoma by targeting CDKN1B.
Yang K; Chen Y; Cui Z; Chen H; Yang L; Zhao J; Luo F; Man S; Zhao J; Jin L
J Oral Pathol Med; 2020 Aug; 49(7):621-629. PubMed ID: 31841247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
